| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | CLP 3.34T | CLP 3.41T | CLP 2.74T | CLP 2.61T | CLP 2.48T |
| Gross Profit | CLP 1.31T | CLP 1.35T | CLP 1.06T | CLP 1.01T | CLP 941.28B |
| Operating Income | CLP 452.51B | CLP 419.74B | CLP 367.27B | CLP 340.35B | CLP 311.58B |
| EBITDA | CLP 444.01B | CLP 579.49B | CLP 485.39B | CLP 457.54B | CLP 428.80B |
| Net Income | CLP 268.70B | CLP 245.96B | CLP 179.56B | CLP 123.21B | CLP 173.07B |
| Balance Sheet | |||||
| Cash & Short-Term Investments | CLP 343.50B | CLP 321.38B | CLP 369.87B | CLP 384.52B | CLP 499.78B |
| Total Assets | CLP 3.48T | CLP 3.29T | CLP 2.92T | CLP 3.01T | CLP 2.95T |
| Total Debt | CLP 1.16T | CLP 1.12T | CLP 1.03T | CLP 1.14T | CLP 1.07T |
| Net Debt | CLP 863.87B | CLP 871.69B | CLP 727.10B | CLP 849.50B | CLP 770.34B |
| Total Liabilities | CLP 2.28T | CLP 2.28T | CLP 2.00T | CLP 2.13T | CLP 1.84T |
| Stockholders' Equity | CLP 1.16T | CLP 976.41B | CLP 886.29B | CLP 855.26B | CLP 1.08T |
| Cash Flow | |||||
| Free Cash Flow | CLP 174.30B | CLP 65.70B | CLP 174.12B | CLP -61.20B | CLP 161.03B |
| Operating Cash Flow | CLP 438.47B | CLP 357.24B | CLP 366.83B | CLP 397.45B | CLP 305.05B |
| Investing Cash Flow | CLP -239.35B | CLP -289.85B | CLP -158.29B | CLP -85.17B | CLP -198.25B |
| Financing Cash Flow | CLP -154.43B | CLP -119.76B | CLP -187.13B | CLP -286.96B | CLP -115.32B |